A detailed history of Northern Trust Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Northern Trust Corp holds 882,841 shares of EXAS stock, worth $51.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
882,841
Previous 1,038,425 14.98%
Holding current value
$51.3 Million
Previous $43.9 Million 37.01%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.43 - $70.83 $6.6 Million - $11 Million
-155,584 Reduced 14.98%
882,841 $60.1 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $2.03 Million - $3.65 Million
49,214 Added 4.98%
1,038,425 $43.9 Million
Q1 2024

May 14, 2024

SELL
$56.27 - $73.77 $5.19 Million - $6.81 Million
-92,295 Reduced 8.53%
989,211 $68.3 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $2.77 Million - $3.55 Million
-46,870 Reduced 4.15%
1,081,506 $80 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $3.79 Million - $5.69 Million
57,423 Added 5.36%
1,128,376 $77 Million
Q2 2023

Aug 11, 2023

SELL
$62.68 - $95.05 $680,830 - $1.03 Million
-10,862 Reduced 1.0%
1,070,953 $101 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $781,513 - $1.17 Million
16,561 Added 1.55%
1,081,815 $73.4 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $383,957 - $672,400
-12,651 Reduced 1.17%
1,065,254 $52.7 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $888,606 - $1.37 Million
27,795 Added 2.65%
1,077,905 $35 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $1.74 Million - $3.73 Million
-48,877 Reduced 4.45%
1,050,110 $41.4 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $20,606 - $29,549
-358 Reduced 0.03%
1,098,987 $76.8 Million
Q4 2021

Feb 08, 2022

SELL
$72.5 - $100.68 $515,040 - $715,230
-7,104 Reduced 0.64%
1,099,345 $85.6 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $6.88 Million - $9.46 Million
76,220 Added 7.4%
1,106,449 $106 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $3.8 Million - $5.65 Million
40,556 Added 4.1%
1,030,229 $128 Million
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $2.57 Million - $3.42 Million
22,032 Added 2.28%
989,673 $130 Million
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $2.65 Million - $3.78 Million
26,630 Added 2.83%
967,641 $128 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $1.01 Million - $1.42 Million
-13,912 Reduced 1.46%
941,011 $95.9 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $2.17 Million - $3.62 Million
38,983 Added 4.26%
954,923 $83 Million
Q1 2020

May 14, 2020

BUY
$37.9 - $104.44 $189,045 - $520,946
4,988 Added 0.55%
915,940 $53.1 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $6.59 Million - $8.47 Million
84,913 Added 10.28%
910,952 $84.2 Million
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $4.44 Million - $6.02 Million
49,143 Added 6.33%
826,039 $74.6 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $15.1 Million - $19.9 Million
168,277 Added 27.65%
776,896 $91.7 Million
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $954,677 - $1.49 Million
15,403 Added 2.6%
608,619 $52.7 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $173,667 - $256,163
-3,099 Reduced 0.52%
593,216 $37.4 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $176,499 - $294,593
-3,655 Reduced 0.61%
596,315 $47.1 Million
Q2 2018

Sep 18, 2018

SELL
$37.84 - $69.96 $285,427 - $527,708
-7,543 Reduced 1.24%
599,970 $35.9 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $33 Million - $61 Million
-872,038 Reduced 58.94%
607,513 $36.3 Million
Q1 2018

May 09, 2018

BUY
$39.82 - $57.53 $39,620 - $57,242
995 Added 0.07%
1,479,551 $59.7 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $1.23 Million - $1.6 Million
-26,482 Reduced 1.76%
1,478,556 $77.7 Million
Q3 2017

Nov 13, 2017

BUY
$37.05 - $47.12 $55.8 Million - $70.9 Million
1,505,038
1,505,038 $70.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.